194 related articles for article (PubMed ID: 16110845)
21. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
[TBL] [Abstract][Full Text] [Related]
23. Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy.
Scholte GH; van Doorn LJ; Cats A; Bloemena E; Lindeman J; Quint WG; Meuwissen SG; Kuipers EJ
Am J Gastroenterol; 2002 Jul; 97(7):1687-95. PubMed ID: 12135019
[TBL] [Abstract][Full Text] [Related]
24. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
25. Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis.
Chen LW; Chang LC; Hua CC; Hsieh BJ; Chen SW; Chien RN
BMC Gastroenterol; 2017 Jan; 17(1):1. PubMed ID: 28049442
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients.
Zerbib F; Lenk C; Sawan B; Cayla R; Broutet N; Carles B; de Mascarel A; Mégraud F; Lamouliatte H
Eur J Gastroenterol Hepatol; 2000 Jul; 12(7):719-25. PubMed ID: 10929896
[TBL] [Abstract][Full Text] [Related]
28. Amount of Helicobacter pylori in gastric mucus during anti-H. pylori treatment.
Furuta T; Takashima M; Futami H; Arai H; Hanai H; Kaneko E
J Gastroenterol Hepatol; 1998 May; 13(5):511-5. PubMed ID: 9641650
[TBL] [Abstract][Full Text] [Related]
29. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.
van der Hulst RW; van der Ende A; Dekker FW; Ten Kate FJ; Weel JF; Keller JJ; Kruizinga SP; Dankert J; Tytgat GN
Gastroenterology; 1997 Jul; 113(1):25-30. PubMed ID: 9207258
[TBL] [Abstract][Full Text] [Related]
30. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
31. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
Meining A; Kiel G; Stolte M
Aliment Pharmacol Ther; 1998 Aug; 12(8):735-40. PubMed ID: 9726386
[TBL] [Abstract][Full Text] [Related]
32. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
33. Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication.
Batista CA; Silva FM; Barbuti RC; Eisig JN; Mattar R; Navarro-Rodriguez T
Arq Gastroenterol; 2009; 46(3):204-8. PubMed ID: 19918687
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa. An 18-month follow-up study].
Gisbert JP; Blanco M; Pajares JM
Rev Clin Esp; 2000 Sep; 200(9):480-4. PubMed ID: 11111392
[TBL] [Abstract][Full Text] [Related]
35. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
[TBL] [Abstract][Full Text] [Related]
36. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Misiewicz JJ; Harris AW; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
Urakami Y; Sano T
J Med Invest; 2003 Feb; 50(1-2):48-54. PubMed ID: 12630568
[TBL] [Abstract][Full Text] [Related]
38. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
Stolte M; Meining A; Schmitz JM; Alexandridis T; Seifert E
Aliment Pharmacol Ther; 1998 Mar; 12(3):247-53. PubMed ID: 9570259
[TBL] [Abstract][Full Text] [Related]
39. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Pilotto A; Perri F; Leandro G; Franceschi M;
Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication.
Yang HB; Sheu BS; Su IJ; Chien CH; Lin XZ
Dig Dis Sci; 1997 Sep; 42(9):1835-40. PubMed ID: 9331144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]